Dr. Nelya Melnitchouk

Doctor Overview

Dr. Nelya Melnitchouk is a surgical oncologist specializing in cancers of the abdomen and gastrointestinal system. She treats patients at Brigham and Women's Hospital and Dana-Farber Cancer Institute. She is director of the peritoneal surface malignancy group at Brigham and Women's. She is also an assistant professor at Harvard Medical School where she teaches surgery.

Dr. Melnitchouk's medical practice focuses on treating patients with abdominal cancers, including peritoneal mesothelioma. She is quite experienced in cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC). Dr. Melnitchouk participates in cancer research alongside her clinical work. In recent years, she has focused on the impact of the war in Ukraine on cancer care and doctor training.

Doctor Fast Facts

Main Specialty: Surgical Oncology

Other Interests & Specialties: Anorectal disorders, appendix tumors, cancer surgery, colon and rectal cancer, colon diseases, Crohn's disease, diverticular diseases, gastrointestinal diseases, HIPEC, inflammatory bowel disease, minimally invasive surgery, rectal diseases and ulcerative colitis.

Certifications, Awards & Accolades: American Board Certifications in Colon and Rectal Surgery and General Surgery, Rudolph Vollman Award

Education & Experience:

• Medical Degree from Albert Einstein College of Medicine
• Residency in General Surgery at Brigham and Women's Hospital
• Fellowship in Colorectal Surgery at New York Hospital-Cornell Medical Center

Publications

Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare Workers. Ann Surg Oncol. 2025 Aug 28.

Consensus Guideline for the Management of Peritoneal Mesothelioma. Ann Surg Oncol. 2025 Jun 25.

Survival Outcomes for Malignant Peritoneal Mesothelioma at Academic Versus Community Hospitals. J Gastrointest Surg. 2022 Jan;26(1):161–70.